1. Revision of Ireland’s Cost-Effectiveness Threshold: New State-Industry Drug Pricing Deal Should Adequately Reflect Opportunity Costs

   • James F. O’Mahony

   Current Opinion Open access 27 July 2021 Pages: 339 - 348

2. National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison

   • Deepshikha Sharma
   • Arun Kumar Aggarwal
   • Shankar Prinja

   Review Article Open access 10 January 2021 Pages: 349 - 364

   

3. A Review of Cost-Effectiveness Studies of Pembrolizumab Regimens for the Treatment of Advanced Non-small Cell Lung Cancer

   • Nan Qiao
   • Ralph Insinga
   • Martin Sénécal

   Review Article Open access 19 January 2021 Pages: 365 - 383

   

4. High-Expenditure Disease in the EU-28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes?

   • Wolfgang Greiner
   • Keyur Patel
   • Tom Vandebrouck

   Review Article Open access 07 January 2021 Pages: 385 - 396

   

5. Onwards and Upwards: A Systematic Survey of Economic Evaluation Methods in Oncology

   • Graeme Ball
   • Mitch Levine
   • Jean-Eric Tarride

   Systematic Review Open access 24 April 2021 Pages: 397 - 410

   

6. State-Level Variations and Factors Associated with Adult Vaccination Coverage: A Multilevel Modeling Approach

   • Diana Garbinsky
   • Shannon Hunter
   • Cosmina Hogea

   Original Research Article Open access 16 April 2021 Pages: 411 - 423

   

7. The Healthcare Cost Burden in Adults with High Risk for Cardiovascular Disease

   • Dat T. Tran
   • Dan Palfrey
   • Robert Welsh

   Original Research Article Open access 23 January 2021 Pages: 425 - 435

   

8. Economic Evaluation of First-Line Pertuzumab Therapy in Patients with HER2-Positive Metastatic Breast Cancer in Japan

   • Kensuke Moriwaki
   • Saki Uechi
   • Kojiro Shimozuma

   Original Research Article Open access 23 January 2021 Pages: 437 - 447

   

9. Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement

   • Taryn A. G. Quinlan
   • Brock Schroeder
   • R. Brett McQueen

   Original Research Article Open access 10 March 2021 Pages: 449 - 458

   

10. Comparison of EQ-5D-3L with QLU-C10D in Metastatic Melanoma Using Cost-Utility Analysis

    • Hansoo Kim
    • Greg Cook
    • Danny Liew

    Original Research Article Open access 23 April 2021 Pages: 459 - 467

    

11. Impact of Letermovir Use for Cytomegalovirus Prophylaxis on Re-Hospitalization Following Allogeneic Hematopoietic Stem Cell Transplantation: An Analysis of a Phase III Randomized Clinical Trial

    • Yoav Golan
    • Yuexin Tang
    • Sanjeet Dadwal

    Original Research Article Open access 19 April 2021 Pages: 469 - 473

    

12. Breathing Synchronised Hypoglossal Nerve Stimulation with Inspire for Untreated Severe Obstructive Sleep Apnoea/Hypopnoea Syndrome: A Simulated Cost-Utility Analysis from a National Health Service Perspective

    • Deirdre B. Blissett
    • Joerg S. Steier
    • Rob S. Blissett

    Original Research Article Open access 28 April 2021 Pages: 475 - 489

    

13. Cost-effectiveness of a Province-wide Quality Improvement Initiative for Reducing Potentially Inappropriate Use of Antipsychotics in Long-Term Care in British Columbia, Canada

    • Asif Raza Khowaja
    • Christina Krause
    • Craig Mitton

    Original Research Article Open access 29 April 2021 Pages: 491 - 504

    

14. Psychometric Validation of the Growth Hormone Deficiency-Child Impact Measure (GHD-CIM)

    • Meryl Brod
    • Michael Højby Rasmussen
    • Aristides Maniatis

    Original Research Article Open access 12 January 2021 Pages: 505 - 518

    

15. Economic Analysis of Transforaminal Lumbar Interbody Fusion Surgery Utilizing a Curved Bone Removal Device

    • John H. Peloza
    • Michael A. Millgram
    • Ely Ashkenazi

    Original Research Article Open access 19 January 2021 Pages: 519 - 531

    

16. Short-Term Excess Healthcare Costs Associated with Cardiovascular Events Among Adults with Type 2 Diabetes in Israel: A Retrospective Cohort Study

    • Cheli Melzer Cohen
    • Nino Hallén
    • Avraham Karasik

    Original Research Article Open access 27 April 2021 Pages: 533 - 544

    

17. Introducing Rotavirus Vaccination in Nigeria: Economic Evaluation and Implications

    • Charles Ebuka Okafor

    Original Research Article Open access 07 January 2021 Pages: 545 - 557

    

18. Correction to: Introducing Rotavirus Vaccination in Nigeria: Economic Evaluation and Implications

    • Charles Ebuka Okafor

    Correction Open access 09 February 2021 Pages: 559 - 559